Could ketamine maintenance therapy reshape neuroscience and behavior research?

What exactly is ketamine maintenance therapy, and why does it matter for research?

Ketamine maintenance therapy means giving repeated doses of ketamine over weeks, months, or even years to sustain an initial benefit—rather than just a single or short course of treatment. This matters because ketamine's rapid effects (within hours for depression or pain) typically fade within days to weeks, so maintenance is needed to prevent relapse. Across the five studies here, maintenance regimens ranged from twice-monthly intravenous infusions [1] to a nasal spray used at home [2], with one patient continuing treatment for five years [5]. For researchers, this opens a window to study how repeated ketamine exposure affects brain structure and function over long periods—something single-dose studies cannot capture.

Where do the studies agree on ketamine maintenance therapy?

All five studies agree that ketamine maintenance therapy is feasible and can be effective for some patients with treatment-resistant depression or chronic pain. In the largest case series here (13 patients), 7 showed acute reduction in suicidal thoughts, and 2 achieved functional remission with long-term treatment [5]. A separate series of 11 patients found lower depression scores during maintenance than at baseline, with 4 continuing treatment at study end [4]. Even the smallest study (5 patients) reported stable or improved depressive symptoms and quality of life over up to 192 days [2]. The fibromyalgia case report documented >50% pain relief sustained with monthly infusions [1]. Across these studies, no serious adverse events were reported—common side effects were mild anxiety, nausea, and temporary blood pressure increases that did not require intervention [2][4]. This consistency across different conditions (depression, pain) and routes (IV, intranasal) strengthens the case that maintenance therapy is a viable clinical strategy worth investigating further.

Where is the evidence conflicting or incomplete?

The studies disagree on how long the benefit lasts and for whom. In one series, 4 of 11 patients stopped ketamine because it stopped working (loss of effect) [4], while another case continued for 5 years with sustained benefit [5]. This suggests that response is highly individual—some patients maintain improvement indefinitely, others lose it within months. The studies also conflict on which factors predict success: one paper found that benzodiazepine use and severe dissociation during treatment were linked to poor outcomes [5], while another emphasized that integrating psychotherapy during the 24-48 hour window after ketamine (when neuroplasticity peaks) might enhance results [3]. No study here directly tested that integration, so it remains theoretical. Critically, all five studies are small (5 to 13 patients) and lack control groups—meaning we cannot rule out placebo effects or natural recovery. The authors themselves repeatedly call for larger, controlled trials [2][4][5]. So while the evidence points toward potential, it is not yet strong enough to reshape neuroscience or behavior research on its own.

How could maintenance therapy reshape neuroscience and behavior research?

If larger studies confirm the findings here, ketamine maintenance therapy could become a powerful tool for studying brain plasticity, inflammation, and consciousness over time. One paper proposes that repeated ketamine sessions induce 'high entropy brain states'—a measure of brain activity complexity—which could be tracked with EEG to optimize dosing [3]. Another highlights ketamine's role as a 'psychoplastogen' that stimulates synaptogenesis (growth of new connections between neurons) and reduces inflammation [3]. Maintenance therapy would allow researchers to measure these effects repeatedly in the same person, linking changes in brain structure to changes in mood or pain over months. It could also help answer behavioral questions: does sustained relief from depression or pain change how people make decisions, form habits, or respond to stress? The 5-year case [5] suggests that long-term ketamine might restore functionality in ways that single doses cannot. However, these are possibilities, not proven outcomes—the research is still in its infancy.

About These Sources

This answer is built on 5 peer-reviewed studies — published from 2018 to 2025, 1 from 2024 or later, 2 in Q1–Q2 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 40 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions